Surgery – Diagnostic testing – Detecting nuclear – electromagnetic – or ultrasonic radiation
Reexamination Certificate
2006-02-02
2010-06-29
Azarian, Seyed (Department: 2624)
Surgery
Diagnostic testing
Detecting nuclear, electromagnetic, or ultrasonic radiation
C382S131000
Reexamination Certificate
active
07747308
ABSTRACT:
Methods, systems and circuits predict cardiotoxicity induced cardiac injury prior to an irreversible state by electronically generating at least one histogram of mean intensities of voxels/pixels in an MRI image of a left ventricle myocardium and electronically determining a likelihood of cardiac injury due to cardiotoxicity based on data from the at least one histogram.
REFERENCES:
patent: 7258670 (2007-08-01), Bardy
patent: 7301016 (2007-11-01), Meyers et al.
patent: 7333845 (2008-02-01), Hundley et al.
patent: 7396654 (2008-07-01), Hayes et al.
patent: 2005/0215883 (2005-09-01), Hundley et al.
patent: WO2004/026140 (2004-04-01), None
Wassmuth et al., “Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging—A pilot study”, American Heart Journal, Jun. 2001, vol. 141, No. 6, pp. 1007-1013, (June.
Hundley et al. “Magnetic Resoance Imaging Determination of cardiac Prognosis” Circulation 106: 2328-2333 (2002).
“General Principals of Software Validation; Final Guidance for Industry and FDA Staff” U.S. Dept of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics and Evaluation Research, 47 pages (Jan. 11, 2002).
Bellenger et al. “Reduction in Sample Size for Studies of Remodeling in Heart Failure by the Use of Cardiovascular Magnetic Resonance”J Cardiovascular Mangn Reson2(4): 271-278 (2000) (Abstract).
Bristow et al. “Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac Catheterization”Annals of Internal Medicine88: 168-175 (1978).
Cardinale et al. “Myocardial Injury Revealed by Plasma Troponin I in Breast Cancer Treated with High-Dose Chemotherapy”Annals of Oncology13: 710-715 (2002).
Cerqueira et al. “Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart: A Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association”Circulation150: 539-542 (2002).
Choi et al. “Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function”Circulation104: 1101-1107 (2001).
Chuang et al. “Importance of Imaging Method Over Imaging Modality in Noninvasive Determination of Left Ventricular Volumes and Ejection Fraction: Assessment by Two- and Three-Dimensional Echocardiography and Magnetic Resonance Imaging”Journal of the American College of Cardiology35(2): 477-484 (2000).
Darty et al. “Nursing Responsibilities During Cardiac Magnetic Resonance Imaging” Department of Internal Medicine (Cardiology Section) and Radiology at the Wake Forest University School of Medicine (no date).
Del Carlo et al. “Cardiac Troponins in Congestive Heart Failure”American Heart Journal138: 646-653 (1999).
Dombernowsky et al. “Doxorubicin and Paclitaxel, a Highly Active Combination in the Treatment of Metastatic Breast Cancer”Seminars in Oncology23(5 suppl 11): 23-27 (1996).
Gehl et al. “Paclitaxel and Doxorubicin in Metastatic Breast Cancer”Seminars in Oncology23(6 suppl 15): 35-38 (1996).
Gerber et al. “Relation Between Gd-DTPA Contrast Enhancement and Regional Inotropic Response in the Periphery and Center of Myocardial Infarction”Circulation104:998-1004 (2001).
Gerber et al. “Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction”, Circulation, vol. 106, No. 9, pp. 1083-1089, (Aug. 27, 2002).
Gianni et al. “Cardiac Function Following Combination Therapy with Taxol (T) and Doxorubicin (A) for Advanced Breast Cancer (ABC)”Proceedings of ASCOvol. 17 (1998) (Abstract).
Gianni et al. “Paclitaxel by 3-Hour Infusion in Combination with Bolus Doxorubicin in Women with Untreated Metastatic Breast Cancer. High Antitumor Efficacy and Cardiac Effects in a Dose-Finiding and Sequence-Finding Study”Journal of Clinical Oncology13(11): 2688-2699 (1995).
Gottdiener et al. “Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction by Radionuclide Cineangiography”Annals of Internal Medicine94(part 1): 430-435 (1981).
Hamilton et al. “Is Imaging at Intermediate Doses Necessary During Dobutamine Stress Magnetic Resonance Imaging?”Journal of Cardiovascular Magnetic Resonance3(4): 297-302 (2001).
Hochster et al. “Cardiotoxicity and Cardioprotection During Chemotherapy”Current Science7: 304-309 (1995).
Hortobagyi “Treatment of Breast Cancer”The New England Journal of Medicine339(14): 974-984(1998).
Hundley et al. “Magnetic Resoance Imaging Determination of cardiac Prognosis”Circulation106: 2328-2333 (2002).
Hundley et al. “Magnetic Resonance Imaging Assessment of the Severity of Mitral Regurgitation: Comparison with Invasive Techniques”Circulation92: 1151-1158 (1995).
Hundley at al. “Relation of Cardiac Prognosis to Segment Location with Apical Left Ventricular Ischemia”The American Journal of Cardiology92: 1206-1208 (2003).
Hundley et al. “Utility of Fast Cine Magnetic Resoance Imaging an display for the Detection of Myocardial Ischemia in patients Not Well Suited for Second Harmonic Stress Echocardiography”Circulation100: 1697-1702 (1999).
Jacobson et al. “Magnetic Resonance Imaging of the Cardiovascular System: Present State of the Art and Future Potential”JAMA259(2): 253-259 (1988).
Jensen at al. “Functional Monitoring of Anthracycline Cardiotoxicity: A Prospective, Blinded, Long-Term Observational Study of Outcome in 120 Patients”Annals of Oncology13: 699-709 (2002).
Judd et al. “Physiological basis of Myocardial Contrast Enhancement in Fast Magnetic Resonance Images of 2-Day-Old Reperfused Canine Infarcts”Circulation92: 1902-1910 (1995).
Kellman et al. “Phase-Sensitive Inversion Recover for Detecting Myocardial Infarction Using Gadolinium-Delayed Hyperenhancement”Magnetic Resonance in Medicine47: 372-383 (2002).
Kim et al. “The Use of Contract-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction”New England Journal of Medicine343: 1445-1453 (2000).
Leandro et al. “Cardiac Dysfunction Late After Cardiotoxic Therapy for Childhood Cancer”The American Journal of Cardiology74:1152-1156 (1994).
Lebwhol et al. “New Developments in Chemotherapy of Advanced Breast Cancer”Annals of Oncology10(suppl 6): S139-S146 (1999).
Lipshultz et al. “Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood”The New England Journal of Medicine324(12): 808-815 (1991).
Longmore et al. “Dimensional Accuracy of Magnetic Resonance in Studies of the Heart”The Lancetpp. 1360-1362 (Jun. 15, 1985).
Lorenz et al. “Normal Human Right and Left Ventricular Mass, Systolic Function, and Gender Differences by Cine Magnetic Resonance Imaging”J Cardiovascular Magn Reson1(1): 7-21 (1999).
Maisel et al. “B-Type Natriuretic Peptide Levels: Diagnostic and Prognostic in Congestive Heart Failure: What's Next?”Circulation150: 2328-2331 (2002).
Martin et al. “Imaging Cardiac Structure and Pump Function”Cardiac Magnetic Resonance Imaging16(2): 135-160 (1998).
McDonagh et al. “Biochemical Detection of Left-Ventricular Systolic Dysfunction”The Lancet351: 9-13 (1998).
Missov et al. “Cardiac Troponin I in Patients with Hematologic Malignancies”Coronary Artery Disease8: 537-541 (1997).
Osoba et al. “Effects on Quality of Life of Combined Trastuzumab and Chemotherapy in women with Metastatic Breast Cancer”Journal of Clinical Oncology20(14): 3106-3113 (2002).
Pagani et al. “Dose-Finding Study of Epidoxorubicin and Docetaxel as First-Line Chem
D'Agostino Ralph B.
Hamilton Craig A.
Hundley William Gregory
Lane Kimberly
Morgan Tim
Azarian Seyed
Myers Bigel Sibley & Sajovec P.A.
Wake Forest University Health Sciences
LandOfFree
Non-invasive systems and methods for the determination of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-invasive systems and methods for the determination of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-invasive systems and methods for the determination of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244048